Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) FCF Margin (2016 - 2025)

Rockwell Medical's FCF Margin history spans 16 years, with the latest figure at 12.02% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1011.0% year-over-year to 12.02%; the TTM value through Dec 2025 reached 1.73%, down 488.0%, while the annual FY2025 figure was 1.73%, 488.0% down from the prior year.
  • FCF Margin reached 12.02% in Q4 2025 per RMTI's latest filing, up from 9.64% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 14.42% in Q3 2024 to a low of 81.0% in Q1 2021.
  • Average FCF Margin over 5 years is 18.16%, with a median of 10.59% recorded in 2023.
  • Peak YoY movement for FCF Margin: tumbled -3849bps in 2021, then surged 5758bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 59.61% in 2021, then soared by 97bps to 2.03% in 2022, then skyrocketed by 81bps to 0.39% in 2023, then soared by 590bps to 1.91% in 2024, then skyrocketed by 531bps to 12.02% in 2025.
  • Per Business Quant, the three most recent readings for RMTI's FCF Margin are 12.02% (Q4 2025), 9.64% (Q3 2025), and 10.45% (Q2 2025).